希望疗法对肺癌患者心理状态、癌因性疲乏和希望水平的影响

Effect of hope therapy on mental state,cancer-related fatigue and hope level in patients with lung cancer

目的:探讨希望疗法应用于肺癌患者后,对患者心理状态、癌性疲乏和希望水平的效果分析。方法:选取某院2018年4月-2019年4月收治的肺癌患者55例作为对照组,进行常规干预;2019年5月-2020年5月收治的肺癌患者55例作为观察组,在对照组的基础上采取希望疗法干预,两组患者均为期干预2个月。比较两组患者癌因性疲乏、抑郁、焦虑、希望水平和生活质量情况。结果:干预后,观察组的CFS中3个维度躯体、情感、认知评分和总分(t=-3.867,-2.843,-3.720,-7.041;P<0.01)及SDS、SAS评分(t=-2.194,-3.400;P<0.05)明显低于对照组,观察组ADHS中2个维度路径思维、动力思维评分及总分明显高于对照组(t=3.987,3.808,5.570;P<0.01),观察组SF-36量表中8个维度评分明显高于对照组(t=2.668,2.045,4.631,3.479,3.521,5.311,3.726,4.048;P<0.05)。结论:希望疗法能有效降低肺癌患者的癌因性疲乏,改善其心理状态和生活质量,提升患者的希望水平。

Objective:To explore the effect of hope therapy on mental state, cancer fatigue and hope level of patients with lung cancer.Methods:Fifty-five patients with lung cancer treated in our hospital from April 2018 to April 2019 were selected as the control group and received routine intervention.Fifty-five patients with lung cancer treated in our hospital from May 2019 to May 2020 were selected as the observation group and treated with hope therapy on the basis of the control group.Patients in both groups were intervened for 2 months.Cancer-related fatigue, depression, anxiety, hope level and quality of life were compared between the two groups.Results:After treatment, the scores of CFS dimensions(physical, emotional, cognitive)and total scores(t=-3.867,-2.843,-3.720,-7.041;P<0.01),SDS and SAS scores in the observation group were significantly lower than those in the control group(t=-2.194,-3.400;P<0.05).The scores of path thinking, dynamic thinking and total score of two dimensions in ADHS of the observation group were significantly higher than those of the control group(t=3.987,3.808,5.570;P<0.01).The scores of 8 dimensions in the observation group were significantly higher than those of the control group(t=2.668,2.045,4.631,3.479,3.521,5.311,3.726,4.048;P<0.05).Conclusion:The hope therapy can effectively reduce cancer-related fatigue, improve their psychological state and quality of life, and enhance the hope level of patients with lung cancer.